Introduction
============

Approximately 2.8% of all hospitalized trauma patients suffer from traumatic peripheral nerve injury ([@B62]). The related severe functional impairment, as well as the consequent socio-economic impact, led to continuous research efforts in this field ([@B61]). If a direct tension free approximation of the nerve stumps is possible, to this day, the epineural nerve suture represents the first line therapy. Alternatively, if tension free coaptation is not achievable, the autologous nerve transplantation (ANT) is the current gold standard ([@B14]). However, given the limited availability of donor nerves and the associated donor site morbidity, new approaches are needed to support in peripheral nerve surgery. Ideally, nerve conduits could provide guidance for the regenerating axons toward the distal nerve stump in the absence of negative side effects like an extended foreign body reaction or an undirected axonal regeneration. Tissue engineering utilized a considerable diversity of materials, but basic techniques like the ANT, firstly described in the 1970's, are still up to date ([@B12]; [@B81]). Various materials have been tested for bridging peripheral nerve defects reaching from non-resorbable materials like silicon ([@B44]) to fully biodegradable materials such as Collagen or PGA ([@B34]; [@B3]; [@B2]). Today, it is a common consent that the material used to support the peripheral nerve regeneration should ideally base on a fully degradable matrix without negatively influencing the regeneration during biodegradation process ([@B71]). However, despite substantial developments in tissue engineering, there is still no material or bio-mimicking concept, which revealed superior results in peripheral nerve regeneration compared to the ANT as the current gold standard for bridging peripheral nerve defects ([@B14]).

Besides the already established materials, Chitosan is a promising relatively novel material in the field of peripheral nerve regeneration. As it is based on the shell of arthropods it is universally available at low costs and provides a fully bioresorbable structure in the absence of toxic metabolites, potentially interfering the regeneration process ([@B20]). Moreover, its specific physical and chemical properties enable to simulate the physiological multilayer architecture of peripheral nerves in artificial tissue engineered nerve conduits. This provides a wide field of potential applications in peripheral nerve surgery such as gap bridging, nerve suture protection or even neuroma prevention.

Previous preclinical and clinical studies investigated these conditions and demonstrated chitosan to support the axonal regeneration ([@B26]; [@B77]), reduce extensive scarring, improve functional recovery ([@B60]) and prevent neuroma formation following peripheral nerve injury ([@B46]). These promising preclinical and early clinical experiences in diverse nerve injury models along with its physiologic features emphasize the future potential of chitosan-based matrices in reconstructive nerve surgery. This work aims to systematically review the current tissue engineering strategies and the current process of clinical implementation.

Properties of Chitosan and Its Impact on Peripheral Nerve Regeneration
======================================================================

The basic component of Chitosan is Chitin, a long-chain polymer of *N*-acetylglucosamine which is harvested by the exoskeletons of arthropods. After cellulose, Chitin is the second most abundant polysaccharide in nature and is aimed to be mainly used in its deacetylated modification (Chitosan) in the field of peripheral nerve surgery ([@B11]). Chitin and chitosan can be classified into the family of the glycosaminoglycans, related to groups of chondroit sulfates, hyaluronic acid, and heparins. However, glycosaminoglycans may be the only polysaccharides with bioactive capabilities ([@B79]). Chitin consists of a linear homopolymer of *N*-acetyl-[D]{.smallcaps}-glucosamine units with β-(1-4)-linkages. After partial deacetylation, chitin becomes chitosan (see [Figure 1](#F1){ref-type="fig"}). Thus it can be can be easily obtained at very low production costs for commercial purposes by alkaline hydrolysis of chitin ([@B20]). Depending on the processing of the chitosan, the degree of acetylation (DOA) can be varied and thus influences the molar mass as well as solvent characteristics ([@B7]).

![Chemical structure of Chitin and Chitosan. The chemical structure of Chitin based on a linear homopolymer of *N*-acetyl-[D]{.smallcaps}-glucosamine units **(A)**. After partial deacetylation chitin becomes chitosan mainly used in peripheral nerve surgery **(B)**.](fncel-13-00104-g001){#F1}

Moreover, the DOA has also been shown to be a relevant factor, influencing survival, proliferation and cell activity of regeneration supporting cells like SC ([@B4]). But, the exact adjustments of chitosan matrices remain challenging, because the mechanical stiffness, the biodegradation time, the geometric architecture as well as the sterilization method potentially influence the axonal regeneration process and thus need to be taken into account throughout the manufacturing process ([@B78]).

In tissue engineered nerve conduits, the biodegradation and physiologic replacement processes start immediately and thus present the central mechanisms of action which influence nerve recovery. In contrast to acid-based materials, like polyglycolic acid (PGA) or polylactide derivates, which undergo a ph decrease during biodegradation or signs of inflammatory foreign body reaction ([@B48]), metabolites of chitosan demonstrated neuroprotective effects during peripheral nerve regeneration.

Here, a degradation product of Chitosan, the Chitooligosaccharide (COS), has been found to promote cell proliferation and prevent apoptosis especially for SC, as the vital cell for a sufficient axonal regeneration ([@B106]; [@B31]). Furthermore, [@B90] attributed these stimulating effects of COS to an accelerated cell cycle leading to increased SC proliferation.

Moreover, COS stimulate the CCL2 expression by down-regulating the miR-327 of the SC, resulting in enhanced macrophage migration to the injury site ([@B104]). In line with this, Bin et al. analyzed the anti-apoptotic effects of carboxymethylated chitosan (CMC) on SC by decreasing caspase-3, -9 and Bax activities and increasing Bcl-2 activities in CMC treated SC. To prevent the SC against oxidative stress, COS led to a reduced activity of malondialdehyde as well as to increased activity of superoxide dismutase activities (SOD) ([@B29]). Further *in vivo* experiments demonstrated a significantly improved peripheral nerve regeneration following daily intravenous injection COS for 6 weeks in an axonotmesis rabbit animal model. Interestingly, the number of regenerated myelinated nerve fibers, the myelin sheath thickness, as well as the compound muscle action potential (CMAP) as the parameter for electrophysiological recovery, has been shown to be significantly superior in COS treated animals. Thus, [@B21] sum up, that COS not only accelerate the peripheral nerve regeneration but also can be seen as a neuroprotective agent after PNI.

Furthermore, the beneficial effect on neural disorders by suppression of the β-amyloid formation and supporting the anti-neuroinflammatory activity underlines the tremendous potential of COS, and consequently of chitosan, in the field of neuropathologies ([@B64]; [@B28]).

Focusing on the tissue engineered designs, in most publications, Chitosan is the main component for a new tissue-engineered nerve conduit to bridge peripheral nerve defects. Interestingly, there are some alternative geometric structures of chitosan to promote axonal regeneration or even prevent neuroma formation.

[@B96] have recently published another concept in the tissue engineering of chitosan by presenting a chitosan-based hydrogel in combination with a poly 3,4- ethylenedioxythiophene. Supported cell adhesion, vitality, and proliferation of PC-12 cells underline the potential of chitosan hydrogel for further neural tissue engineering. Interestingly tissue engineered concepts based on chitosan focused not only on the treatment of PNI but also for neuroma prevention. [@B46] applied, mircrocrystallic chitosan to the proximal nerve stump after PNI and showed less autotomy behavior and minor axonal sprouting as a key ability for neuroma prevention in the future.

Mechanical Properties and Topographic Strategies in Tissue Engineering of Chitosan
==================================================================================

Mechanical Properties and Challenges
------------------------------------

In a medical application, chitosan has already a long history due to its biocompatibility and to its non-toxic, biodegradable properties ([@B20]).

Not only in the field of peripheral nerve surgery chitosan plays a crucial role, but also for wound healing or as a drug delivery system. Referring to the peripheral nerve, low mechanical strength has been a tremendous challenge in the early phase after implantation of chitosan and its derivates. Matrices of chitosan showed decreased stability under physiological conditions ([@B45]; [@B36]) and therefore make it not suitable for the translational application. Modifications have been made to improve mechanical stability by designing an internal architecture by puncturing the chitosan while molding procedures with needles ([@B84]). Alternatively, [@B1] developed a new uni-directional temperature gradient leading to a chitosan scaffolds incorporated with longitudinal microfibers. Unfortunately, the scaffold presents an appropriate mechanical strength under *in vitro* conditions but fail to show stability under physiological *in vivo* circumstances. To improve the mechanical strength of chitosan, further adjustments like additional cross-linking by supplementation of chitin ([@B98]) or formaldehyde ([@B13]) have been published. The mechanical stability of the chitosan is also affected by the degree of acetylation (DOA). Higher DOA has been reported to improve the stability of chitosan and lead to a superior keratinocytes cell adhesion ([@B7]). Referring to the neural cell lineage, acetylation rates of 0.5 and 11% showed more and longer neurites of regeneration of dorsal chick root ganglions neurons compared to other concentration. However, cell viability of 0.5% was approximately eight times higher compared to a DOA of 11%. Thus, surface modifications of chitosan films referring to the cell viability and cell adhesion can clearly be modified by the DOA ([@B19]) and needs to be addressed in the future tissue engineering for chitosan materials. In line with this, supporting cells, like SC, also benefit from a low DOA by presenting a better cell spreading and proliferation ([@B92]).

However, for translation applications, the mechanical strength of the material to prevent the collapse of the material is essential as well as the ability for an inner lining of regenerating axons. Exemplary, Wang et al. present a chitosan two-layer approach with an oriented inner layer of nanofibers and a random outer layer with superior stability compared to random fiber mesh tubes ([@B86],[@B87]).

Forms of Chitosan and Topographic Concepts
------------------------------------------

Several forms and techniques of chitosan have been published in literature reaching from hydrogels ([@B105]; [@B69]; [@B56]; [@B16]), films ([@B66]; [@B95]; [@B51]), microspheres ([@B101]) or tubes ([@B36]; [@B84]; [@B73]) in the field of peripheral nerve surgery.

### Hydrogels

Hydrogels are a frequently applied form in the field of tissue engineering because of the similarity to the extracellular matrix, and the modest way of processing.

[@B20] presented, after the hydrolyzation of chitin, a hydrogel-based chitosan tube with superior mechanical strength, measured by the transverse compressive test. Chitosan Hydrogel has also been used as an alternative to the fibrin glue or even to the epineural suture after peripheral nerve lesion ([@B69]). Further *in vitro* studies combine chitosan hydrogels with hydroxyapatite as a source for calcium ions to modify mechanical and biological properties. Cytotoxic and pro-inflammatory tests could mark the biocompatibility of this hydrogel solution independently of the tested composition ([@B55]).

Interestingly, *in vivo* studies with a chitosan/glycerol-beta-phosphate disodium salt hydrogel presented an impaired peripheral nerve regeneration for 10 mm sciatic nerve defect compared to chitosan tubes filled with SC suspension or culture medium ([@B105]). Hydrogels as an inner filling in combination with chitosan tubes tested under *in vivo* conditions led to further enhanced peripheral nerve regeneration.

As drug delivery system, chitosan hydrogels have also been explored by a continuous delivery of methylprednisolone. Functional recovery of the rat's facial ([@B5]) and sciatic nerve ([@B49]) was accelerated for animals with a supplementary methylprednisolone delivery.

Hydrogels of other components, like Hyaluronic hydrogels ([@B51]) fibrin nanofiber hydrogels ([@B16]) or simvastatin/Pluronic F-127 hydrogels ([@B24]) have been frequently combined with chitosan tubes. Axonal regeneration and motor functional recovery was improved by applying these hydrogels as inner filling for chitosan tubes.

### Films

In the field of peripheral nerve surgery, chitosan films are applied directly for enhancing peripheral nerve regeneration but also as an inner architecture for nerve guides to bridge peripheral nerve defects. Mechanical stability and biocompatibility were proven for neural cells and peripheral nerves tissue engineering ([@B66]).

[@B50] combined a chitosan nerve tube with a supporting inner layer of a chitosan film over 15 mm long distance defects of a rat's sciatic nerve lesion and presented superior axonal regeneration as well functional recovery compared to hollow non-modified chitosan tubes.

Chitosan films have been modified with several other components by crosslinking or incorporation. Proanthocyanidin was crosslinked to chitosan films with gelatine and showed improved mechanical properties, a decreased biodegradation rate, superior cell adhesion as well as improved proliferation compared to non-crosslinked gelatin or chitosan alone ([@B40]). Similar results have been found by the crosslinking of chitosan and hyaluronic in a polyelectrolyte multilayer film ([@B72]). Incorporation of polyethylene oxid with chitosan revealed a superior water permeability and a ratio-depended antibacterial effects as well as improved mechanical strength compared to non-modified chitosan films ([@B108]).

### Microspheres

Chitosan can also be manufactured as microspheres or microparticles mainly used for drug delivery. Chitosan microspheres loaded with NGF has been incorporated to collagen-chitosan scaffolds for a rat's sciatic nerve and led to promising results in functional outcome in combination with microchannels as inner lining ([@B101]) as well as combined with a chitosan nerve guide conduit for reconstruction of facial nerve injuries ([@B43]). Further developments in tissue engineering enable an additional loading of cores-shell poly(lactide-co-glycolide)-chitosan microparticles as drug delivery system for continuous release of NGF ([@B102]).

Tubes and Inner Architecture
----------------------------

Different strategies of the treatment of peripheral nerve injuries based on chitosan have been explored in the literature, reaching from chitosan filament mesh tubes to chitosan-based nerve conduits. Exemplary, chitosan tubes were described by [@B80] coupled with synthetized laminin under *in vivo* conditions to bridge a 15 mm sciatic nerve lesion. Despite the modification with the laminin peptides YIGSR and IKVAV, no superior results compared to the ANT have been shown ([@B80]). Further developments of tissue engineering led to chitosan tubes with a triangular inner surface and an additional coating with hydroxyapatite as well as laminin and laminin-1 peptides. Histological findings presented the beneficial effects of a triangular inner architecture for peripheral nerve regeneration. However, despite histological regeneration is like the ANT, delayed functional recovery was shown after 12 weeks of regeneration ([@B36]). Addressing the essential need for inner guidance to bridge long distance peripheral nerve defects, porous chitosan tubular scaffold with chitosan fiber-based yarns with interconnected micropores were created ([@B84]). [@B86] also published alternative strategies for an inner lining by combining chitosan film tube as an outer layer with a nano/microfiber mesh as inner guidance. Different degrees of deacetylation were tested and compared to an ANT. Histological finding presents a better cell migration and attachment as well as neurite outgrowth for scaffolds with deacetylation rate of 93% compared to scaffolds with 78% ([@B86]).

Furthermore, an additional mobilization with polarized β-tricalcium phosphate particles led to superior results in histological findings compared to non-polarized mesh tubes and similar results to the ANT ([@B88]). [@B75] followed another approach presenting nanostructured hollow tubes with an additional crosslinking of genipin. Biological performance of this modified hollow tubes was assessed focussing on cell adhesion, viability, and proliferation ([@B75]). Recently, chitosan flat membranes crosslinked with dibasic sodium phosphate alone and combined with γ-glycidoxypropyltrimethoxysilan showed increased water stability and stiffness under *in vitro* conditions. For a 1 cm median nerve gap, chitosan conduits associated with γ-glycidoxypropyltrimethoxysilan promoted nerve fiber regeneration and functional recovery similar to the autograft ([@B18]).

Chitosan can also be combined with autologous materials by utilizing a chitosan tube with fresh skeletal muscle fibers as an inner layer to bridge nerve defects in the rat's median nerve. Interestingly, Neuregulin-1 is upregulated for chitosan tubes with internal muscle fibers but not for hollow tubes and may be crucial to further improve axonal nerve regeneration over long nerve lesions ([@B70]).

Biochemical Properties and Surface Modifications
------------------------------------------------

Cell affinity for the neural cell lineage plays a crucial role to support neural regeneration. Therefore, chitosan is loaded with laminin or poly-lysine and led mainly to superior neurite outgrowth compared to the non-blended alternative ([@B27]). [@B10] applied PC12 cell culture to test cell affinity in poly-L-lysine different blended chitosan nerve tubes. Interestingly, the hydrophobicity of the poly-[L]{.smallcaps}-lysine in combination with the increased surface charge might be the reason for the increased cell attachment, growth, and differentiation ([@B10]). Furthermore, increased concentration of poly-[D]{.smallcaps}-lysine not influence cell survival but can inhibit neurite outgrowth ([@B11]).

Compositions of chitosan and gelatin have also been tested referring to the cell affinity and the potential to neurite outgrowth. Despite a decreased cell viability, chitosan blended with gelatine was able to show superior neurite outgrowth and in the first days of cell culture compared to PLL containing materials ([@B47]).

Alternative surface modification to promote peripheral nerve regeneration, are the YIGSR (Tyr-Ile-Gly-Ser-Arg) and IKVAV (Ile-Lys-Val-Ala-Val) sequences, which are known to modify receptor specific neural cell adhesion as well as to support neurite outgrowth. [@B35] were able to bond the YIGSR (Tyr-Ile-Gly-Ser-Arg) and IKVAV (Ile-Lys-Val-Ala-Val) peptides to molecular aligned chitosan. The peptides A3G75 and A3G83 of the laminin alpha chain LG4 modules promote neurite outgrowth. Conjugated peptides of the LG4 and LG5 modules to chitosan membranes presented improved cell attachment and neurite outgrowth for PC12 cells ([@B38]). A2G94 peptide is expressed by the Laminin alpha2 chain and led to a promoted alpha6beta1-mediated cell attachment as well as neurite outgrowth after conjugation in a chitosan tube ([@B83]).

Furthermore, Laminin-modified chitosan membranes significantly enhance SCs attachment and affinity for the guided peripheral nerve regeneration. Percentage of laminin incorporation is significantly higher by using the oxygen plasma technique compared to conventional chemical methods ([@B32]). Laminin has also been used to bond an additional glycin spacer to nano/microfiber mesh surface of the chitosan tube. SC affinity has been further improved by these surface modification ([@B32]). The combination of negatively charged heparin and positively charged γ-aminopropyltriethoxysilane (APTE) on porous chitosan scaffolds led to superior SC proliferation, attachment, and biological activity after seeding was shown under *in vitro* conditions ([@B42]).

Experimental Chitosan-Based Hybrid Strategies to Promote Peripheral Nerve Regeneration Under Experimental Conditions
====================================================================================================================

The recent literature describes a variety of different types of hybrid strategies which aim to combine the advantages of chitosan with specific characteristics of other materials (see [Table 1](#T1){ref-type="table"}). The following section presents such chitosan hybrid strategies and discusses their potential role in reconstructive nerve surgery.

###### 

Recently published chitosan-based hybrid models for peripheral nerve regeneration.

  Nerve tube                           Filler/Internal architecture/ Conduit modification   Cells or growth gactors   Nerve           Animal       Defect size (in mm)   Controls                                                              Recovery Time in weeks   Methods                                                                                         Outcome                                                                                                                                                                                         Author
  ------------------------------------ ---------------------------------------------------- ------------------------- --------------- ------------ --------------------- --------------------------------------------------------------------- ------------------------ ----------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------
  Chitosan-collagen film               --                                                   --                        Sciatic nerve   Rat          5--10                 ANT                                                                   12                       Electrophysiological measurements, Histological analysis                                        Chitosan-collagen tubes presented similar recovery for 5 mm and inferior recovery for 10 mm compared to ANT                                                                                     [@B91]
  Chitosan-collagen scaffold           RGD-Peptide                                          --                        Sciatic nerve   Rat          15                    ANT                                                                   8                        Electrophysiological measurements, Retrograde tracing, Histological analysis, Immunochemistry   Chitosan-collagen scaffolds with RGD-Peptide modification showed superior results to non-modified scaffold but less recovery to ANT                                                             [@B95]
  Chitosan-collagen scaffold           --                                                   --                        Sciatic nerve   beagle dog   30                    ANT                                                                   12                       Electrophysiological measurements, Retrograde tracing, Histological analysis, Immunochemistry   Chitosan-collagen scaffold revealed functional nerve recovery equivalent to the ANT without additional exogenous delivery or cell transplantation                                               [@B67]
  Chitosan conduit                     PGA filaments                                        --                        Sciatic nerve   beagle dog   30                    ANT                                                                   24                       Electrophysiological measurements, Retrograde tracing,Histological analysis Immunochemistry     Similiar distribution patterns for myelinated axons were able to show for chitosan/PGA conduits                                                                                                 [@B89]
  Chitosan/PGA conduit                 --                                                   --                        Sciatic nerve   rat          10                    ANT                                                                   12--24                   Electrophysiological measurements, Retrograde tracing, Histological analysis                    Even after maintained treatment after 3--6 months, chitosan/PGA conduits peripheral nerve regeneration is possible, however, an immediate repair presented superior functional results          
  PLGA/chitosan nanofiber mesh tubes   Nanofibers                                           SC                        Sciatic nerve   rat          10                    PLGA/ chitosan nanofiber mesh tubes without additional cell seeding   12                       Electrophysiological measurements, Histological analysis, Immunochemistry                       PLGA/chitosan nanofiber mesh tubes seeded with SC led to superior results for functional recovery compared to non-seeded tubes                                                                  [@B103]
  PLGA/chitosan conduit                --                                                   CNTF                      tibial nerve    dog          25                    ANT                                                                   12                       Electrophysiological measurements, Histological analysis, Immunochemistry                       PLGA/chitosan-CNTF presented slightly inferior recovery compared to ANT in the electrophysiological measurements and histological analysis, but better results than non-blended PLGA/chitosan   [@B74]
  Chitosan- nanofiber conduit          Nanofibers with polyethylene glycol solution (PEG)   --                        Sciatic nerve   rat          10                    ANT                                                                   12                       Histological analysis, Immunochemistry, Functional testing, Muscle Mass Measurement             Chitosan nanofiber conduit/PEG revealed superior results compared to chitosan nanofiber alone, but inferior recovery compared to ANT                                                            [@B54]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

Collagen
--------

Advantages of an adjustable biodegradation time as well as the relief of non-toxic components during biodegradation, make collagen a precious and well-investigated material supporting peripheral nerve healing ([@B14]). Considering the accepted biomimicking concept for the treatment of peripheral nerve lesions, [@B57] developed an epineurium-mimicking chitosan conduit by a chemical composition of collagen, chitosan, and hyaluronic acid. Testing on mHippoE-18 mouse hippocampal cells, cell stimulation without cytotoxicity has been shown. As an alternative geometric design, one of the first chitosan-collagen films presented by [@B91] showed promising results in a functional recovery for bridging peripheral nerve lesion of 5--10 mm. Progress in tissue engineering further expanded the biomimicking approach for peripheral nerve reconstruction; thus Xiao combined a hybrid nerve guide based on collagen-chitosan and added an Arg-Gly-Asp (RGD) sequence, which is a well-known pattern and mostly used for supporting cell-adhesion abilities in tissue engineering. This led to superior results in histological and functional recovery compared to nerve conduits lacking an additional RGD sequence ([@B95]). Recently, a collagen/chitosan nerve scaffold was introduced by [@B67] fabricated by an "unidirectional freezing process" followed by further freeze-drying ([@B15]). On the basis of a collagen and chitosan suspension, this new scaffold was applied for bridging a peripheral nerve defect of 30 mm of the beagle's sciatic nerve. Based on the results of the electrophysiological assessment, retrograde tracing as well as histological evaluation, this collagen-chitosan nerve scaffold presented results equivalent to the ANT. If further experimental research confirms these identical recovery results via artificial conduits, such strategies will next be investigated in future clinical trials ([@B67]).

Polyglycolic Acid (PGA)
-----------------------

Polyglycolic acid has been widely used in the field of bridging peripheral nerve defects. Focusing on the reconstruction of extended- distance peripheral nerve defects PGA conduits filled with laminin-soaked collagen scaffolds or PGA-collagen fibers were found to promote axonal regeneration over a nerve lesion of up to 80 mm ([@B82]). Thus, it is reasonable to combine the beneficial effects of PGA with the potential of chitosan to further optimize the regeneration supporting conduit features. Therefore, [@B89] developed a dual-component artificial nerve graft with an outer microporous conduit of chitosan and an inner layer of filaments PGA. In a beagle dog animal model with sciatic nerve lesion of 30 mm and a recovery interval of 6 months, the chitosan/PGA group showed a similar distribution pattern of myelinated fiber diameter compared to the ANT ([@B89]).

Polylactic Acid (PLA) and Poly(Lactic-Co-glycolic Acid) (PLGA)
--------------------------------------------------------------

The combination of chitosan and polylactide (CH-PLA) fibers presented a higher tensile strength and a lower tendency for swelling compared to chitosan fibers alone. The combination of a chitosan-based outer layer with an inner lining by (CH-PLA) fibers led to a guided axonal regeneration and thereby to the possibility to bridged long-distance peripheral nerve defects.

Furthermore, the CH-PLA fibers have been tested as a continuous release system of attached growth factors such as NGF and thereby induced a continuous outgrowth of PC12 cells as receptors for epidermal growth factor (EGF) both known to promote peripheral nerve regeneration ([@B33]). Thus, CH-PLA fibers can be manufactured for gradient delivering not only for NGF but also other relevant growth factors by loading them into the alginate layers. Wu et al. emphasized the vast potential of these CH-PLA fibers, especially for a guided axonal regeneration for long-gap nerve repair ([@B94]). In line with this, Shen and colleagues bridged a peripheral nerve lesion of 25 mm of the canine tibial nerve in a dog animal model. Histological results illustrated that the PLGA/chitosan conduits were capable of providing peripheral nerve regeneration after 12 weeks. Results similar to the ANT can be reached by combining the PLGA/chitosan conduit with an additional coating of the ciliary neurotrophic factor ([@B74]). Moreover, the average maximum nerve fiber diameter and motor function have been improved by introducing dorsal root ganglion-derived SC to poly-(lactic-co-glycolic acid)/chitosan nerve scaffold for 10 mm sciatic nerve lesion in the rat ([@B103]). However, materials based on PLA and PLGA suffer under a pH-decrease of the microenvironment during degradation and leading to an impaired of axonal regeneration ([@B14]).

Polyethylene Glycol
-------------------

Another promising hybrid approach is to combine chitosan-based nanofiber conduits with an additional filling of polyethylene glycol solution. In a 10 mm nerve defect of the rat's sciatic nerve, the superior functional outcome has been shown for animals treated with a substitute of the polyethylene solution. In contrast, functional recovery compared to the ANT showed clear inferior results for the experimental groups ([@B54]). Furthermore, challenges of the chitosan in tissue engineering referring to the disadvantage in the processing of three-dimensional tubular forms without heating processing methods like extrusion or casting ([@B1]), were addressed by Nawrotek and colleagues by developing a tubular chitosan-carbon nanotube through the electrodeposition method. This conduit provided an excellent cell-adhesion, cell-proliferation, and cell-viability as well as structural stability for 28 days under *in vivo* conditions ([@B57]).

To sum up, hybrid concepts with chitosan have been well explored in literature, mostly for bridging peripheral nerve defects and led to promising results in peripheral nerve regeneration. Interestingly, the hybrid approach mainly revealed superior results of axonal recovery compared to concepts with chitosan alone. However, an exact differentiation of the effects of chitosan and the added material in a hybrid approach is not possible. Furthermore, hybrids concepts present the possibility of a tailored biodegradation as well as the embedding of growth factors or additional cell seeding related to the needs of peripheral nerve regeneration.

Additional Cell Seeding Combined with Chitosan-Based Treatment Strategies
=========================================================================

Nerve regeneration through chitosan-based nerve tubes can be promoted by conduit enrichment via supportive molecules like laminin or growth factors as well as additional cell seeding (see [Table 2](#T2){ref-type="table"}).

###### 

Recently published incorporation advances of supportive cells or growth factors in the peripheral nerve system.

  Nerve tube                                                                                                     Filler/Internal architecture/ Conduit modification                             Cells or growth factor      Nerve                 Animal   Defect size (in mm)   Controls                                          Total recovery time in weeks   Methods                                                                                                                       Outcome                                                                                                                                                                                                                             Author
  -------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ --------------------------- --------------------- -------- --------------------- ------------------------------------------------- ------------------------------ ----------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------
  Chitosan conduit                                                                                               Skin fibroin filamentous fillers                                               Skin-derived SC             Sciatic nerve         Rat      10                    Acellular nerve graft                             12                             Electrophysiological measurements, Retrograde tracing. Histological analysis. Immunohistochemistry, Muscle mass measurement   Histological and functional analysis were showed superior results compared to acellular nerve                                                                                                                                       [@B107]
  Laminin-modified multi -walled nerve tube                                                                      Inner layer laminin-modified chitosan; outer layer silicon                     BMSC                        Sciatic nerve         Rat      10                    Empty silicon tube. physiological sciatic nerve   16                             Histological analysis, Retrograde Tracing, Immunochemistry, Functional testing                                                Additional seeding with BMSC on the multi-walled nerve tube showed superior results in terms of regrowth, muscle mass of gastrocnemius, function recovery and retrograde tracing compared to empty silicon tubes                    [@B30]
  Poly-3-hydroxybutyrate nerve conduit                                                                           Coating with chitosan                                                          BMSC                        Sciatic nerve         Rat      10                    ANT                                               8                              Electrophysiological measurements, Retrograde tracing, Histological analysis                                                  Histological analysis revealed a beneficial effect of PHB/chitosan with supplementary seeding of BMSC compared to non-seeded nerve conduits. However, results still remain inferior compared to the ANT                             [@B63]
  Chitosan film                                                                                                  Chitosan films placed around the nerve coaptation                              BMSC                        Sciatic nerve         Rat      --                    Sciatic nerve transection and end-to-end suture   8                              Electrophysiological measurements, Histological analysis, Immunochemistry, Functional testing                                 BMSC seeded chitosan films presented improved functional electrophysiological and histomorphometric recovery compared to non-seeded chitosan films. Results were also superior to the control group                                 
  Chitosan/ poly(lactic glycolic acid) (PLGA)-based neural scaffold                                              Chitosan conduit combined with about 1000 longitudinal aligned PLGA fibers     BMSC                        Sciatic nerve         Dog      50                    ANT                                               24                             Electrophysiological measurements, Retrograde tracing, Histological analysis, Muscle mass measurement                         (PLGA)-based neural scaffolds seeded with BMSC indicate nerve recovery close to the ANT and better results to non-seeded nerve scaffolds, referring to the results of electrophysiological measurements and histological analysis   [@B15]
  Chitosan poly(lactic-co- glycolic acid) (PLGA)-based neural scaffold                                           Chitosan conduit combined with about 1000 longitudinal aligned PLGA fibers     BMSC                        Sciatic nerve         Dog      60                    ANT                                               52                             Retrograde Tracing, Histological analysis, Immunochemistry, Functional testing                                                The outcome of (PLGA)- based neural scaffolds seeded with BMSC is similar to the ANT and showed better recovery compared to non-seeded scaffold                                                                                     [@B97]
  Chitosan/silk fibroin nerve scaffold                                                                                                                                                          Bone marrow nuclear cells   Sciatic nerve         Rat      10                    ANT                                               12                             Electrophysiological measurements. Histological analysis, Immunochemistry, Functional testing                                 Similar peripheral nerve regeneration of seeded chitosan/fibroin nerve scaffolds compared to the ANT and better recovery than non-seeded scaffolds                                                                                  [@B99]
  Autologous vein conduit combined with chitosan-β- glycerophosphate e-nerve growth factor (C/GP-NGF) hydrogel   Autologous vein graft filled with chitosan modified hydrogel                   NGF                         Buccal branch nerve   Rat      5                     ANT                                               12                             Electrophysiological measurements. Histological analysis. Functional testing                                                  Autologous veins filled with (C/GP-NGF) hydrogel led to similar degree of functional and electrophysiological recovery like the ANT as well as to superior results to vein conduits blended with NGF solution                       [@B6]
  Chitosan conduit                                                                                               NGF immobilization by Genipin cross linking                                    NGF                         Sciatic nerve         Rat                            10 ANT                                            24                             Electrophysiological measurements. Histological analysis. Functional testing, Muscle Mass Measurements.                       Considering the wet-weight ratio of the gastrocnemius muscle, the ANT presented superior results to the modified nerve conduit. Electrophysiological measurements and histological analysis revealed similar                        [@B85]
  GDNF- laminin blended chitosan nerve tube                                                                      Chitosan tubes blended with laminin and glial cell-line derived nerve growth   GDNF                        Sciatic nerve         Rat                            8 ANT                                             12                             Functional testing. Muscle Mass Measurements                                                                                  Especially sensory recovery is supported by the supplementation of GDNF to the chitosan nerve tube; Motoric recovery revealed similar in comparison to non-blended nerve tubes                                                      [@B65]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

Additional Cell-Seeding With Schwann Cells (SC)
-----------------------------------------------

The proliferative effect of chitosan on SC and inhibiting effect on the fibroblast growth has already been shown by [@B41]. Thereby, chitosan has the potential to support the axonal regeneration by increasing the number of SC and may prevent scar tissue formation after peripheral nerve lesion ([@B41]). Further investigations regarding biocompatibility among SC chitosan scaffolds or fibers were conducted by [@B100], leading to the conclusion that chitosan has an excellent neuroglial cell affinity with the ability to be an excellent cell carrier system after implantation. Chitosan membranes or fibers showed almost no cell toxicity for SC considering the results in the MTT Assay ([@B100]).

As mentioned above, the DOA of the chitosan is crucial for the solvent characteristics and molar mass. Carvalho has shown that acetylation of 5% results in higher cell proliferation and phenotypic expression of SC-like cells compared to chitosan membranes with acetylation rates of 1% or 2% ([@B4]). The combination of SC with a chitosan nerve conduit substituted with self-fibroin filamentous fillers showed superior regeneration results compared to non-seeded chitosan conduits regarding the histological and functional outcome ([@B107]).

Additional Cell-Seeding With Bone Marrow Stromal Cells (BMSC)
-------------------------------------------------------------

Bone marrow stromal cells seeded nerve conduits, in general, have shown to be a successful concept for bridging peripheral nerve defects and promoting axonal regeneration ([@B52]; [@B39]; [@B2]). Consequently, strategies to enhance peripheral nerve regeneration by BMSC seeded chitosan-based nerve guides has also been described. [@B30] published a two-component nerve tube with an inner layer based on laminin-modified chitosan and a silicon-based outer layer with a supplementary seeding of BMSC. As the control group, non-seeded laminin modified-chitosan scaffolds and empty silicone tubes have been utilized. After a regeneration period of 16 weeks and following histological investigations, hyperplasia tissue enriched with eosinophils and macrophages has been found. In this context, the importance of the inflammation after PNI, induced by these cells, was emphasized by the author ([@B30]). In line with this, a chitosan-coated poly-3-hydroxybutyrate nerve conduit has been seeded with BMSC to bridge a 10 mm sciatic nerve lesion and led to superior results in functional recovery compared to non-seeded control group. However, the ANT showed still the best results of functional recovery ([@B63]). Similar results have been assessed through [@B53] by exhibiting significant superior effects in which group? in the electromyography, nerve fiber density and myelinated axon diameter ([@B53]). For bridging long distance peripheral nerve injuries of 50 mm or even 60 mm, in a dog sciatic nerve, chitosan/poly(lactic-co-glycolic acid) (PLGA)-based neural scaffolds have been combined with BMSC and evaluated by electrophysiology, retrograde tracing, and histology after recovery of 6 or 12 months. The results led to a nearly similar degree of functional regeneration compared to the ANT ([@B15]; [@B97]). Interestingly, [@B99] was able to show, that Bone Marrow Mononuclear Cells joined with a chitosan/silk fibroin scaffold survived at least 2 weeks under *in vivo* conditions associated with an improved axonal guidance. Nearly similar results for functional recovery was accomplished compared to the ANT in the CatWalk gait analysis after 12 weeks of recovery ([@B99]). However, SC harvested during nerve surgery need long cultivation times to reach sufficient cell numbers for reimplantation and are associated with a loss of function related to donor's nerve.

Alternatively, BMSC can be harvested through bone marrow biopsy and revealed cell plasticity that can be adapted to the conditions of peripheral nerve regeneration ([@B39]). However, the operation procedure is associated with surgical risks, like infection, bleeding, etc. Furthermore, the stability of differentiation has to be taken into account, BMSC have the ability to differentiate to SC-like cells under *in vitro* conditions but also have the capacity to re-differentiate to stem cell under the absence of the required factors, which is associated with a higher malignity degeneration rate ([@B22]).

Most current concepts of additional cell-seeding in peripheral nerve surgery remain as a proof principle because of the potential donor site morbidities, long lasting cultivation times before implantation and instability of cell differentiation ([@B2]). Thereby, translational concepts with additional cell seeding based on chitosan are strongly restricted.

Chitosan-Based Delivery Systems for Growth Factors
==================================================

In tissue engineered delivery systems the release kinetics of growth factors play a crucial role for axonal regeneration. Recently, a variety of different concepts have been published using chitosan as a delivery system for growth factors while peripheral nerve regeneration (see [Table 2](#T2){ref-type="table"}).

Nerve Growth Factor (NGF)
-------------------------

[@B68] were able to show a continuous delivery of bioactive NGF in low nanogram doses for 15 days. A nerve conduits of polyelectrolyte alginate/chitosan was coated with layers of poly(lactide-co-glycolide) (PLGA) to control the delivery of embedded NGF ([@B68]). Moreover, the relevance of continuous delivery of NGF by using chitosan as carrying material and its synergetic effects have been marked by [@B6]. The combination of vein conduits filled with a chitosan-β-glycerophosphate-NGF hydrogel presented superior histological, functional and electrophysiological recovery compared to non-filled vein conduits ([@B6]). This underlines the capacity of chitosan to be an excellent delivering system for growth factors related to the peripheral nerve regeneration.

Furthermore, chitosan nerve conduits with a supplementary immobilization of NGF via genipin cross-linking, were compared to the ANT for a 10 mm-long sciatic nerve gap with 24 weeks recovery time. The crosslinked nerve conduit was superior compared to a non-crosslinked control but not to the ANT and led to inferior results in the electrophysiology and axon density compared to the gold standard. Thus, the real potential of additional NGF-application is hard to evaluate in this study design ([@B85]). The indication of chitosan tubes is not only limited to the treatment of PNI but can also be extended for nerve compression syndromes. [@B102] developed a chitosan-sericin scaffold for a continuous delivering of NGF. After application, a better functional recovery, as well as superior histological results has been demonstrated, probably caused by the beneficial effects of degradation products and the corresponding inducement of mRNA levels of GDNF, EGR2, NCAM as well as down-regulation levels of inflammatory genes ([@B102]).

Glial Cell Line-Derived Growth Factor (GDNF)
--------------------------------------------

The beneficial effects of GDNF on the peripheral nerve regeneration, like the support of motoneuron regeneration, acceleration of axonal regeneration and the prevention of muscle atrophy are known in the literature ([@B9]; [@B37]). Further developments in tissue engineering led to chitosan conduits enriched with laminin and GDNF. Non-prepared laminin-loaded chitosan tubes were compared to laminin-loaded chitosan tubes with supplementation of GDNF and used to bridge a nerve lesion of 10 mm. An additional GDNF blending explicated a significant superior sensory recovery compared to unblended chitosan tubes ([@B65]).

Fibroblast Growth Factor-2 (FGF-2)
----------------------------------

Fibroblast growth factor-2 is one of the 22-member of the fibroblast growth factor family. In association with heparin or heparin sulfate proteoglycan, a variety of different effects has been reported including potent effects on angiogenesis and cell differentiation in the central nervous system. Chitosan-nanoparticles have been utilized as drug delivery systems for FGF-2. The chitosan scaffolds with incorporated FGF-2 microspheres reviewed superior results in cell survival and growth of neural stem cells compared to non-incorporated chitosan scaffolds under *in vitro* conditions ([@B93]). In line with this, chitosan scaffolds cross-linked with heparin and FGF-2 were assessed for cytocompatibility, attachment, and survival of neural stem cells ([@B76]). Alternatively, FGF-2 concentration can be increased by overpressing SC seeded in a chitosan hydrogel as an inner filling for a chitosan tube. Neural and Vascular (NVR) gel as inner filling has the obstacle to impair axonal outgrowth in a rat's sciatic nerve model. However, this challenge could be overcome by consistent delivery of FGF-2 of overexpressing SC and led to a significant extent in neurite outgrowth compared to free FGF-2 delivery or non-modified Neonatal Rat SC ([@B51]).

Platelet-Derived Growth Factor (PDGF)
-------------------------------------

Platelet-derived growth factor (PDGF) has been shown to support the migration of bone marrow stromal cells. Chitosan scaffolds have been loaded with chitosan-encapsulated PDGF microspheres and investigated for the biocompatibility of neural progenitor cells. Directional migration and growth of these cells were shown for scaffolds with additional PDGF incorporation. Chitosan microspheres underline their potential as a drug delivery system by releasing 52% of the PDGF in 4 weeks under *in vitro* conditions without a burst release ([@B8]). The beneficial effect of PDGF on neural stem progenitor cells by promoting the cell survival and cell differentiation to oligodendrocytes is described in the literature (Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury; Endogenous and exogenous CNS derived stem/progenitor cell approaches for neurotrauma). In combination with chitosan channels and a continuous release of PDGF osmotic pump, neural stem progenitor cells have been significantly enhanced in cell survival under *in vivo* conditions ([@B25]).

Translational Concepts of Chitosan-Based Nerve Tubes
====================================================

Yet, the application of chitosan-based nerve conduits beneath experimental research as translational concepts has not been explored sophisticatedly. Only a few studies have already implemented chitosan tubes in clinical practice and evaluated the functional outcome after application.

In first clinical treatments, the combination of a chitosan-PGA nerve conduit was utilized to bridge a long-distance defect of 35 mm of the median nerve distal to the bicep's aponeurosis. During a 3-year follow-up period sensory and motor function recovered satisfactorily to M4 and S3+ levels in testing. However, this case report need to be amended by further clinical studies to prove the clinical value of this nerve conduit ([@B17]). Similar results have been found by [@B23] after bridging a 30 mm nerve defect of the median nerve with the same nerve conduit 2 years later. In June 2014, the first unaccompanied chitosan-based nerve conduit, named Reaxon^®^has been launched by Medovent GmbH (Mainz, Germany). Reaxon^®^was developed in accordance with the international standard DIN EN ISO 13485 and can be manufactured in different sizes depending on the diameter of the nerve. Nerve defects with a size up to 26 mm can be bridged in the clinical setting ([@B59]). Furthermore, Reaxon^®^cannot only be used as tubulization-technique for bridging the peripheral nerve defects but also as a protector for the nerve coaptation after a tension-free epineural suture ([@B58]).

Thus, besides several studies investigated beneficial effects of chitosan and its derivates in preclinical *in vitro* and *in vivo* models, the functional outcome after traumatic sensory nerve lesions can significantly be enhanced by a supplementary use of Reaxon^®^as protection for the epineural suture in daily clinical routine (see [Figure 2](#F2){ref-type="fig"}). In a double-blinded, randomized, prospective clinical trial, after a 6-months follow-up, a 6.3 mm two-point-discrimination has been found for patients treated with the additional chitosan-based conduit compared to the control group with two-point discrimination of 8 mm. This significant enhancement of the tactile gnosis is a relevant parameter for functional recovery of the hand ([@B60]). The capability of Reaxon^®^has been further investigated by Ronchi et al. by combining the chitosan tube with skeletal muscle fibers of the pectoralis muscle to bridge a 10 mm nerve lesion of the median nerve. Biomolecular analysis has shown an increased production and release of Neuregulin, as a key factor for SC survival and vitality. However, functional recovery and morphometric analyses presented no significant differences compared to hollow chitosan tubes. The author considered, beneficial effects of an inner lining by an additional muscle application is more indicated for nerve lesion of an extended distance than for a nerve lesion size of 10 mm in humans ([@B70]).

![Translational Concepts in daily clinical practice. Chitosan nerve tube protects the epineural nerve coaptation **(A)**. Magnification of the chitosan-based nerve tube for covering the epineural suture of the third proper palmar digital **(B)**. Protection of the epineural nerve coaptation by a chitosan-based nerve tube in a model **(C)**. **(A,B)** has been taken during clinical routine care.](fncel-13-00104-g002){#F2}

In the future, the possible clinical application of Chitosan in the field of peripheral nerve surgery is vast and can be used for bridging peripheral nerve lesion, protecting the epineural coaptation or even for neuroma prevention.

Referring to the findings of [@B46], new developments in material science led to chitosan-based nerve caps, which may have the capacity to limit neuroma formation by combining a mechanical obstacle with an additional material-related biochemical barrier for unguided axonal sprouting. Based on the material properties, recent material science concepts, such as chitosan gel, film or microcrystals, for an easier application of the material is also possible.

In conclusion, the capability of chitosan as a sophisticated partner in the peripheral nerve regeneration has been explored in several *in vitro* and *in vivo* experimental approaches. Not only the cell biocompatibility of chitosan on neural cells was shown but also beneficial effects on the differentiation and proliferation on SC as well as BMSC. Moreover, COS, as the metabolite of chitosan during biodegradation, is a neuroprotective agent during peripheral nerve regeneration and a direct stimulator for SC. Under *in vivo* conditions, chitosan was able to bridge peripheral nerve defects up to 60 mm in combination with a chitosan/poly(lactic-co-glycolic acid) (PLGA)-based neural scaffold combined with BMSC. First human trials in 2011 presented sensory recovery after chitosan tube implantation for a median nerve lesion. Recently, the first chitosan-based nerve guide was launched for clinical application and led to superior sensory recovery by using it as a biochemical protector for the site of the epineural nerve coaptation. However, given the only few human clinical trials investigating chitosan conduits, the effect on the outcome following all kinds of nerve surgery (decompression, defect reconstruction, and neuroma prevention) and thereby its potential value have to be evaluated. However, considering the first results of clinical trials and previous *in vitro* and *in vivo* experiments, chitosan has an immense potential to be a valuable partner for the peripheral nerve surgeon in the future.

Conclusion
==========

The relevance and application of chitosan in the field of peripheral nerve surgery are tremendous and can principally be separated between the support axonal regeneration by giving mechanical guidance and stability (as chitosan tube, inner filling or epineural suture protector) or being used as drug delivery system.

Chitosan has good biocompatibility of the peripheral nervous system, and mechanical properties make custom-made biodegradation possible. To overcome mechanical instability in a variety of different approaches in tissue engineering reaching from chitosan microspheres to chitosan hydrogel have been explored. Especially hybrid-models based on chitosan can be tailored to the demands of nerve recovery and showed promising results on all levels of peripheral nerve regeneration. In translational concepts, chitosan has been generally proven to support functional recovery, however, the clinical evidence is limited to a small number of studies yet. Future investigations should focus on the clinical outcome after application of chitosan as a drug delivery system or mechanical guidance/protection after peripheral nerve injury.
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